Aino Latva-Rasku


Doctoral Student, Internal Medicine (Department of Clinical Medicine)

aehyyp@utu.fi







Areas of expertise
Expertese

Publications

Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study (2019)
Upsala Journal of Medical Sciences
Axel Åkerblom, Jonas Oldgren, Aino Latva-Rasku, Lars Johansson, Vera Lisovskaja, Cecilia Karlsson, Jan Oscarsson, Pirjo Nuutila
(
A1 Journal article – refereed)

The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients (2019)
Diabetes Care
Diabetes
Latva-Rasku A, Honka MJ, Kullberg J, Mononen N, Lehtimaki T, Saltevo J, Kirjavainen AK, Saunavaara V, Iozzo P, Johansson L, Oscarsson J, Hannukainen JC, Nuutila P
(
A1 Journal article – refereed)

A Partial Loss-of-Function Variant in AKT2 is Associated with Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin Sensitive Tissues: a Genotype-Based Callback Positron Emission Tomography Study (2018)
Aino Latva-Rasku, Miikka-Juhani Honka, Alena Stančáková, Heikki A. Koistinen, Johanna Kuusisto, Li Guan, Alisa K Manning, Heather Stringham, Anna L Gloyn, Cecilia M Lindgren, the T2D-GENES Consortium, Francis S Collins, Karen L Mohlke, Laura J Scott, Tomi Karjalainen, Lauri Nummenmaa, Michael Boehnke, Pirjo Nuutila, Markku Laakso
(
A1 Journal article – refereed)

Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: A positron emission tomography study (2018)
European Journal of Endocrinology
Miikka-Juhani Honka, Aino Latva-Rasku, Marco Bucci, Kirsi A Virtanen, Jarna C Hannukainen, Kari K Kalliokoski, Pirjo Nuutila
(
A1 Journal article – refereed)


Last updated on 2017-17-11 at 06:16